Tcheng, J E <br/><br/>
Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment.  [electronic resource] 

 -  The American journal of cardiology  May 1999 
 - 7E-11E p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9149(99)00084-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Antibodies, Monoclonal--pharmacology<br/>Clinical Trials as Topic<br/>Coronary Disease--drug therapy<br/>Eptifibatide<br/>Humans<br/>Immunoglobulin Fab Fragments--pharmacology<br/>Peptides--pharmacology<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Tirofiban<br/>Tyrosine--analogs & derivatives